JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Nice
NICE
$6.83B
| $7M | ﹤0.01% |
76,170
-27,973
| -27% | -$2.38M |
2015 Q1
11 quarters
|
|
2302
Ashland
ASH
$3.14B
| $6.99M | ﹤0.01% |
98,136
-34,419
| -26% | -$2.37M |
2013 Q2
18 quarters
|
|
|
NEE.PRQ
2303
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $6.95M | ﹤0.01% |
99,940
+17,628
| +21% | +$1.22M |
2016 Q1
7 quarters
|
|
|
ALXN
2304
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.94M | ﹤0.01% |
58,000
+10,000
| +21% | +$1.22M |
2017 Q1
3 quarters
|
|
2305
H.B. Fuller
FUL
$2.7B
| $6.93M | ﹤0.01% |
128,590
+83,906
| +188% | +$4.66M |
2014 Q4
12 quarters
|
|
2306
PUT
Fluor
FLR
$6.6B
| $6.93M | ﹤0.01% |
+134,100
| New | +$6.24M |
2017 Q4
0 quarters
|
|
2307
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$30.3B
| $6.92M | ﹤0.01% |
+91,400
| New | +$6.65M |
2017 Q4
0 quarters
|
|
|
SNI
2308
PUT
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $6.92M | ﹤0.01% |
+81,000
| New | +$6.69M |
2017 Q4
0 quarters
|
|
2309
Supernus Pharmaceuticals
SUPN
$2.46B
| $6.92M | ﹤0.01% |
173,527
+172,017
| +11,392% | +$6.8M |
2015 Q4
8 quarters
|
|
2310
LendingTree
TREE
$345M
| $6.91M | ﹤0.01% |
20,292
+17,607
| +656% | +$5M |
2017 Q1
3 quarters
|
|
|
ACGN
2311
DELISTED
Aceragen Inc
ACGN
| $6.9M | ﹤0.01% |
24,054
-676
| -3% | -$193K |
2015 Q1
11 quarters
|
|
|
FNSR
2312
DELISTED
Finisar Corp
FNSR
| $6.89M | ﹤0.01% |
338,738
+11,908
| +4% | +$248K |
2015 Q3
9 quarters
|
|
|
KNL
2313
DELISTED
Knoll, Inc.
KNL
| $6.89M | ﹤0.01% |
299,100
+84,216
| +39% | +$1.76M |
2013 Q2
18 quarters
|
|
2314
Genworth Financial
GNW
$3.52B
| $6.89M | ﹤0.01% |
2,214,740
+987,704
| +80% | +$3.41M |
2013 Q2
18 quarters
|
|
2315
Banco Bilbao Vizcaya Argentaria
BBVA
$148B
| $6.88M | ﹤0.01% |
809,626
-52,016
| -6% | -$443K |
2013 Q2
18 quarters
|
|
|
TPCO
2316
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $6.86M | ﹤0.01% |
389,975
+156,876
| +67% | +$2.54M |
2014 Q3
13 quarters
|
|
|
ANDV
2317
PUT
DELISTED
Andeavor
ANDV
| $6.86M | ﹤0.01% |
60,000
| – | – |
2017 Q2
2 quarters
|
|
2318
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.1B
| $6.85M | ﹤0.01% |
61,425
+20,386
| +50% | +$2.21M |
2016 Q1
7 quarters
|
|
2319
CALL
Canadian Solar
CSIQ
$765M
| $6.85M | ﹤0.01% |
406,100
+386,300
| +1,951% | +$6.64M |
2016 Q2
6 quarters
|
|
2320
CALL
TripAdvisor
TRIP
$982M
| $6.84M | ﹤0.01% |
+198,600
| New | +$7.18M |
2017 Q4
0 quarters
|
|
2321
Southside Bancshares
SBSI
$909M
| $6.81M | ﹤0.01% |
202,078
+37,119
| +23% | +$1.31M |
2014 Q4
12 quarters
|
|
2322
Customers Bancorp
CUBI
$2.5B
| $6.8M | ﹤0.01% |
261,592
+144,442
| +123% | +$4.1M |
2014 Q1
15 quarters
|
|
2323
Knowles
KN
$3.27B
| $6.8M | ﹤0.01% |
463,756
-27,518
| -6% | -$430K |
2014 Q1
15 quarters
|
|
2324
PUT
Las Vegas Sands
LVS
$23.8B
| $6.78M | ﹤0.01% |
97,500
+57,500
| +144% | +$3.84M |
2016 Q4
4 quarters
|
|
2325
CALL
Prudential Financial
PRU
$39B
| $6.75M | ﹤0.01% |
58,700
+2,500
| +4% | +$281K |
2016 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.